Original news and analysis on international IP policy
From Third World Network: London, 3 Nov (Sangeeta Shashikant) The United States and the Least Developed Countries (LDCs) at the World Trade Organization have reached agreement ad referendum on a pharmaceutical patent exemption for a duration of 17 years, according to trade diplomats.
According to a prominent researcher in the field of neglected tropical diseases, the World Intellectual Property Organization has a prominent role to play in addressing the lack of research and development for neglected diseases.
A joint symposium of the World Health Organization, World Trade Organization and World Intellectual Property Organization this week included several panels on how trade, public health and intellectual property could positively interact to increase access to medicines.
Negotiations have been ongoing at the World Trade Organization over the extension of a waiver allowing least-developed countries not to grant or enforce intellectual property rights on pharmaceutical products.
Trade, health, and intellectual property came together today as the heads of three specialised international organisations held an annual symposium to stimulate discussions on how the three can best help public health, and notably access to medicines in developing countries.
CAPE TOWN, South Africa - While Médecins Sans Frontières have blamed stock-outs of ‘Aluvia’ on the refusal to licence a patent for a generic of the HIV medicine in South Africa by AbbVie pharmaceutical company leading to persistent supply problems, the company said it has taken measures to address the problem.
A revealing independent review to be published this week on WIPO Re:Search, the World Intellectual Property Organization initiative for development of medical products for neglected tropical diseases, malaria and tuberculosis, gives a set of recommendations to ensure the sustainability and success of the initiative.
International trade agreements are sometimes demonised as the Grand Plan imposed by major powers in cahoots with multinational corporations. Intellectual property rights is a particular target, as is the case currently with the Trans-Pacific Partnership (TPP), and previously with the World Trade Organization’s Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). "The Making of the TRIPS Agreement", the insightful, unofficial collected memoirs of 17 of the agreement’s key authors, plus one editor, challenges that view in two ways, writes Peter Ungphakorn.
World Health Organization members and stakeholders were invited to provide comments this month on the organisation’s framework to spur preparedness for future influenza pandemics and ensure treatments will reach developing countries. The framework is expected to undergo a review in 2016. The advisory group to the initiative also went through issues such as contributions by manufacturers, and how to deal with genetic sequence data.
Alongside the recent World Intellectual Property Organization General Assembly, the WIPO Global Challenges Division presented WIPO Re:Search, a public-private consortium to facilitate research on neglected tropical diseases, tuberculosis and malaria.
At the recent TEDx CERN event, Intellectual Property Watch caught up with bioethicist and legal philosopher Matthew Liao, to reflect on challenging moral questions raised by new advances in computing and neuroscience allowing for the manipulation of human thoughts and memories. Liao reflected on whether we should use drugs and technology to erase traumatic memories, and if individuals have a moral obligation to themselves to remember certain events.
Informal negotiations at the World Trade Organization between least developed countries (LDCs) and some developed countries over a public health extension for LDCs could not be finalised in time to be taken to the intellectual property committee meeting today and…